Company: TELO
Filing Date: 2025-02-18
Form Type: 8-K
Source: 0001493152-25-007080
Chunk: 0

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-18
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Events

Telomir
Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related
Macular Degeneration (AMD)

Telomir
Pharmaceuticals, Inc. (NASDAQ: TELO) (“ Telomir” or the “ Company”), a leader in age-reversal science, today announced
key findings from a recently conducted preclinical study evaluating its lead compound, Telomir-1 human retinal cell lines reduce oxidative stress caused by copper and iron exposure age-related macular degeneration (AMD)

Summary
of Study Conducted

  Objective: To assess Telomir-1’s ability to mitigate oxidative stress in human retinal cell        
  Method: Human retinal cells were exposed to copper and iron to induce oxidative stress. Telomir-1  
  Results:                                                                                           

  Copper                                                                                            
  and iron exposure significantly increased ROS levels, accelerating oxidative stress and cellular  
  damage.                                                                                           
 ────────────────────────────────────────────────────────────────────────────────────────────────────
  Telomir-1                                                                                         
  Telomir-1                                                                                         
  These                                                                                             

Telomir
is initiating AMD disease models in vivo efficacy

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                                     TELOMIR                                      
  Dated:      February 18, 2025      By:                       /s/                
                                     Name:                     Erez               
                                     Title:                    Chief